Sowmya Kaur

Sowmya Kaur, executive vice president at Navitas Life Sciences, has worked across multiple aspects of the industry, including operations, business development, and strategy with leading industry players. With a career spanning 2 decades, she has a track record of building and leading clinical development engagements across emerging markets and delivering a portfolio of projects.

Articles by Sowmya Kaur

A case study of how an emerging biotech moved from targeted monitoring to full clinical operations and site management across multiple studies. Credit: Stock.Adobe.com/PHOTO4U

Flexible Clinical Operations and Site Management Across a Diversified Biotech Portfolio: An Application of Quality by Design and Risk-Based Oversight

ByJanel Shelton-DeMagnus,Ndimuangu Hilton,Sowmya Kaur

October 12th 2026

How a phased CRO partnership built on ICH E6(R2) and E6(R3) principles supported a multi-indication biotech portfolio.

Latest Updated Articles

Trending on Applied Clinical Trials Online

AI and Patient Recruitment: Can Predictive Promise Drive True Transformation?

Beyond Outreach: Structural Drivers of Representation in Clinical Trials

The Test Is the Ticket: Building Smarter Pathways to Clinical Trial Participation

Start Study Budgets Sooner With AI-Enabled Protocol Translation

Real-Time Data, Right-Time Decisions: Rethinking Analysis Frequency in RBQM